Scarica l'app Stockscreener
5.5677
3.09%
0.1777
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AHCO Giù?
Forum
Previsione
Precedente Chiudi:
$5.39
Aprire:
$5.41
Volume 24 ore:
726.31K
Relative Volume:
0.33
Capitalizzazione di mercato:
$742.42M
Reddito:
$3.24B
Utile/perdita netta:
$-66.64M
Rapporto P/E:
-10.49
EPS:
-0.5308
Flusso di cassa netto:
$219.38M
1 W Prestazione:
-4.36%
1M Prestazione:
-50.43%
6M Prestazione:
-46.26%
1 anno Prestazione:
-40.38%
Intervallo 1D:
$5.36
$5.575
Intervallo di 1 settimana:
$5.32
$5.95
Portata 52W:
$5.21
$13.43
Adapthealth Corp Stock (AHCO) Company Profile
Nome
Adapthealth Corp
Settore
Industria
Telefono
610-424-4515
Indirizzo
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AHCO
Adapthealth Corp
|
5.565 | 755.10M | 3.24B | -66.64M | 219.38M | -0.5308 |
ABT
Abbott Laboratories
|
116.29 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
329.50 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.06 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.44 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.59 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-08 | Downgrade | Jefferies | Buy → Hold |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-05-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-05-10 | Downgrade | Stifel | Buy → Hold |
| 2023-05-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-07-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-03-18 | Iniziato | Truist | Buy |
| 2021-01-26 | Iniziato | BofA Securities | Buy |
| 2020-12-10 | Iniziato | UBS | Buy |
| 2020-08-10 | Iniziato | Canaccord Genuity | Buy |
| 2020-07-01 | Ripresa | SVB Leerink | Outperform |
| 2020-06-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-01-31 | Iniziato | Stifel | Buy |
| 2020-01-07 | Iniziato | Jefferies | Buy |
| 2019-12-11 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Iniziato | Deutsche Bank | Buy |
Mostra tutto
Adapthealth Corp Borsa (AHCO) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth C - The National Law Review
AdaptHealth (NASDAQ:AHCO) Faces Pressure After Weak Quarterly Results - Kalkine Media
AdaptHealth breach exposed health records of one in 13 Vermonters - Vermont Daily Chronicle
AdaptHealth Breach Exposed Health Records of One in 13 Vermonters - Compass Vermont
AdaptHealth Corp. (NASDAQ:AHCO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AdaptHealth's Market Cap Drops To US$696m Leaving Insiders With Losses - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. (AHCO) Q2 2026 Earnings: EPS Misses Estimates by 48.1% on Unreported RevenueNet Profit Margin - Vinanet
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Investors to Learn More About the Investigation | NDAQ:AHCO | Press Release - Stockhouse
AdaptHealth (NASDAQ:AHCO) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
AdaptHealth Corp. (AHCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of ... - Caledonian Record
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information - GlobeNewswire
AdaptHealth Director Dale B. Wolf Updates Stock Purchase Price in Amended SEC Filing - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Investors to Connect - ACCESS Newswire
Kenneth Samet Bought 94% More Shares In AdaptHealth - webull.com
5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call - Yahoo Finance
AdaptHealth Corp. (AHCO) Stock Forecasts - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages AdaptHealth Corp - The National Law Review
AdaptHealth misses Q2 revenue and earnings esti... - Pluang
AdaptHealth Corp. (AHCO) Securities Investigation NoticeLevi & Korsinsky - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AdaptHealth Corp. (AHCO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Time To Worry? Analysts Just Downgraded Their AdaptHealth Corp. (NASDAQ:AHCO) Outlook - webull.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
AdaptHealth | 8-K: ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2026 RESULTS - Moomoo
AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript - AOL.com
AdaptHealth (NASDAQ:AHCO) Trading Up 10.5% on Insider Buying Activity - MarketBeat
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth - Yahoo Finance
AdaptHealth at Canaccord Genuity’s 46th annual growth conference: refocus deepens - Investing.com
AdaptHealth Corp. (AHCO) Stock Analysis: Navigating a 75% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AdaptHealth Corp. (AHCO) And Encourages Investors to Reach Out - ACCESS Newswire
Adapthealth director Dale Wolf buys $244,600 in company stock - Investing.com India
Adapthealth director Dale Wolf buys $244,600 in company stock By Investing.com - Investing.com Australia
Adapthealth director Kenneth Samet buys $149,930 in shares By Investing.com - Investing.com South Africa
Adapthealth director Kenneth Samet buys $149,930 in shares - Investing.com
AdaptHealth (NASDAQ:AHCO) Director Purchases $149,930.00 in Stock - marketbeat.com
AdaptHealth director Dale B. Wolf acquires common shares worth $244,200 - Bitget
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving AdaptHealth Corp. (AHCO) - GlobeNewswire
AdaptHealth (NASDAQ:AHCO) Reaches New 52-Week LowWhat's Next? - MarketBeat
ADAPTHEALTH CORP. : LEERINK PARTNERS CUTS TARGET PRICE TO $7 FROM $12 - Bitget
Weekly Recap: Revenue guidance reset and e‑commerce JV, app growth - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AdaptHealth Corp. (AHCO) And Encourages Stockholders to Reach Out - ACCESS Newswire
AdaptHealth (AHCO) Reports A Net Loss And Goodwill Impairment, Is The Stock A Bargain? - Sahm
Why AdaptHealth Stock Plummeted This Week - Yahoo Finance
Avoiding Lag: Real-Time Signals in (AHCO) Movement - Stock Traders Daily
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law - FinancialContent
AdaptHealth Corp. $AHCO Shares Sold by Reinhart Partners LLC. - MarketBeat
AdaptHealth (NASDAQ:AHCO) Downgraded by Wall Street Zen to Hold - MarketBeat
AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now - webull.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AdaptHealth Corp. (AHCO) And Encourages Stockholders to Connect - ACCESS Newswire
Adapthealth Corp Azioni (AHCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adapthealth Corp Azioni (AHCO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WOLF DALE B | Director |
Aug 06 '26 |
Buy |
6.37 |
20,000 |
127,400 |
143,234 |
| WOLF DALE B | Director |
Aug 07 '26 |
Buy |
5.86 |
20,000 |
117,200 |
34,000 |
| Schuster III Russell E. | Chief Commercial Officer |
Jul 01 '26 |
Sale |
10.44 |
11,275 |
117,711 |
125,263 |
1.35%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):